Drug intelligence / Profile preview

Urolind

Development stage
Unknown
Lead developer
Germania Pharmazeutika
Modality
Small Molecules
Administration
Oral
01

Overview

Urolind is a dietary supplement marketed by Germania Pharmazeutika in Austria, specifically formulated to support prostate health and normal bladder function. The product contains a combination of pumpkin seed extract (*Cucurbita pepo*), pomegranate extract (*Punica granatum*), and the trace element selenium. Pumpkin seed extract is traditionally utilized for its phytosterol content, which is believed to help manage symptoms of benign prostatic hyperplasia (BPH) and overactive bladder by modulating urinary tract function. Pomegranate extract provides antioxidant polyphenols, while selenium serves as a critical cofactor for antioxidant enzymes, protecting urogenital tissues from oxidative damage and supporting normal spermatogenesis. Urolind is available as an over-the-counter product in capsule form.

Brand names
Urolind
02

Targets

Uropathogenic bacterial adhesin

Beyond the preview

Go deeper on Urolind.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urolind.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call